Literature DB >> 6722099

Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose.

J E Bodwell, N J Holbrook, A Munck.   

Abstract

Glucocorticoid -receptor complexes from intact rat thymus cells incubated with [3H]dexamethasone at 0 degree C are in the nonactivated form and do not bind to DNA-cellulose. Upon being warmed, they are transformed to activated complexes that bind to DNA-cellulose at 0 degree C. We have found that treatment of dexamethasone-receptor complexes with the sulfhydryl-modifying reagents methyl methanethiosulfonate ( MMTS ) and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), either before or after the warming, inhibits subsequent binding to DNA-cellulose. The effects of these reagents can be reversed at 0 degree C by dithioerythritol and other sulfhydryl-containing compounds. These results provide the first clear evidence that sulfhydryl-modifying reagents inhibit the binding of activated dexamethasone-receptor complexes to DNA-cellulose and suggest that sulfhydryl groups may be located in or near the DNA binding domain of the rat thymus glucocorticoid-receptor complex. Furthermore, addition of dithioerythritol at 0 degree C to nonactivated receptor complexes that have been treated with MMTS or DTNB produces a substantial increase in the capacity of these complexes to bind to DNA-cellulose, raising the possibility that sulfhydryl groups may be associated with a region on the receptor that plays a critical role in the activation process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722099     DOI: 10.1021/bi00302a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma.

Authors:  Susan T Stephenson; Lou Ann S Brown; My N Helms; Hongyan Qu; Sheena D Brown; Milton R Brown; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol       Date:  2015-03-06       Impact factor: 10.793

2.  Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system.

Authors:  Y Makino; K Okamoto; N Yoshikawa; M Aoshima; K Hirota; J Yodoi; K Umesono; I Makino; H Tanaka
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 3.  Compartmentalization of redox signaling through NADPH oxidase-derived ROS.

Authors:  Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

4.  Unnatural amino acid packing mutants of Escherichia coli thioredoxin produced by combined mutagenesis/chemical modification techniques.

Authors:  R Wynn; F M Richards
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

Review 5.  Modulation of nuclear receptor function by cellular redox poise.

Authors:  Eric L Carter; Stephen W Ragsdale
Journal:  J Inorg Biochem       Date:  2014-01-21       Impact factor: 4.155

Review 6.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

Review 7.  Current status of NADPH oxidase research in cardiovascular pharmacology.

Authors:  Bruno K Rodiño-Janeiro; Beatriz Paradela-Dobarro; María Isabel Castiñeiras-Landeira; Sergio Raposeiras-Roubín; José R González-Juanatey; Ezequiel Alvarez
Journal:  Vasc Health Risk Manag       Date:  2013-07-25

Review 8.  Glucocorticoids in Sepsis: To Be or Not to Be.

Authors:  Jolien Vandewalle; Claude Libert
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

9.  Effects of administration of ascorbic acid and low-dose hydrocortisone after infusion of sublethal doses of lipopolysaccharide to horses.

Authors:  Melinda J Anderson; Alina S Ibrahim; Bruce R Cooper; Andrew D Woolcock; George E Moore; Sandra D Taylor
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.